Friday, March 8, 2019
Home »
» Medical News Today: The FDA approve esketamine nasal spray for severe depression
Medical News Today: The FDA approve esketamine nasal spray for severe depression
Federal regulators have approved the use of the new prescription nasal spray drug esketamine for depression that has not responded to other treatments.
Related Posts:
Medical News Today: What are the types of depression?There are several different types of depression, which is a common mental health condition. Learn about their symptoms and who is at risk in this article. … Read More
Medical News Today: What to know about nasal vestibulitisNasal vestibulitis is a type of bacterial infection that affects the opening of the nose. In this article, learn more about the causes and treatments, plus when to see a doctor. … Read More
Medical News Today: The 13 emotions that music evokes in usHow can listening to music make us feel? A new study involving participants from different cultures has identified 13 possible emotions that music evokes. … Read More
Medical News Today: Is it bronchitis or pneumonia?Bronchitis and pneumonia are two illnesses that people often confuse because they have many overlapping symptoms. Learn more about the differences here and when to see a doctor. … Read More
Medical News Today: What to know about Crohn's and the eyesAlthough most Crohn's disease symptoms involve the gut, the condition can also affect the eyes. Learn more about eye-related Crohn's symptoms here. … Read More
0 comments:
Post a Comment